Cathay Biotech Inc.
688065.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥5,346,794 | CN¥5,390,218 | CN¥6,294,604 | CN¥9,628,544 |
| Short-Term Investments | CN¥469 | CN¥469 | CN¥469 | CN¥469 |
| Receivables | CN¥470,435 | CN¥385,523 | CN¥475,347 | CN¥275,223 |
| Inventory | CN¥1,180,528 | CN¥1,466,356 | CN¥1,573,638 | CN¥1,185,121 |
| Other Curr. Assets | CN¥323,117 | CN¥328,102 | CN¥143,229 | CN¥231,920 |
| Total Curr. Assets | CN¥7,386,914 | CN¥7,570,668 | CN¥8,475,499 | CN¥11,394,612 |
| Property Plant & Equip (Net) | CN¥9,848,549 | CN¥10,231,362 | CN¥6,669,851 | CN¥2,984,075 |
| Goodwill | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Intangibles | CN¥685,040 | CN¥703,854 | CN¥777,875 | CN¥768,459 |
| Long-Term Investments | CN¥133,311 | CN¥142,732 | CN¥49,037 | CN¥52,745 |
| Tax Assets | CN¥210,368 | CN¥158,877 | CN¥88,279 | CN¥49,874 |
| Other NC Assets | CN¥757,295 | CN¥25,880 | CN¥1,766,740 | CN¥948,559 |
| Total NC Assets | CN¥11,634,563 | CN¥11,262,705 | CN¥9,351,782 | CN¥4,803,713 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥19,021,477 | CN¥18,833,373 | CN¥17,827,281 | CN¥16,198,325 |
| Liabilities | – | – | – | – |
| Payables | CN¥1,440,650 | CN¥1,651,950 | CN¥1,060,056 | CN¥302,257 |
| Short-Term Debt | CN¥1,246,912 | CN¥1,530,623 | CN¥166,848 | CN¥743,510 |
| Tax Payable | CN¥42,848 | CN¥55,541 | CN¥36,132 | CN¥50,012 |
| Deferred Revenue | CN¥0 | CN¥12,997 | CN¥17,806 | CN¥170,252 |
| Other Curr. Liab. | CN¥79,922 | CN¥124,250 | CN¥116,304 | CN¥1,721 |
| Total Curr. Liab. | CN¥2,917,856 | CN¥3,409,753 | CN¥1,424,183 | CN¥1,217,740 |
| LT Debt | CN¥613,263 | CN¥245,332 | CN¥960,500 | CN¥0 |
| Deferred Rev, NC | CN¥389,286 | CN¥0 | CN¥404,385 | CN¥293,028 |
| Deferred Tax Liab, NC | CN¥0 | CN¥0 | CN¥960,500 | CN¥0 |
| Other NC Liab. | CN¥0 | CN¥405,178 | CN¥404,385 | CN¥0 |
| Total NC Liab. | CN¥1,002,550 | CN¥650,510 | CN¥1,364,885 | CN¥293,028 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Liabilities | CN¥3,920,405 | CN¥4,060,263 | CN¥2,789,068 | CN¥1,510,768 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥583,378 | CN¥583,378 | CN¥583,278 | CN¥416,682 |
| Retained Earnings | CN¥2,306,558 | CN¥2,068,601 | CN¥1,807,249 | CN¥1,460,383 |
| AOCI | CN¥359,644 | CN¥225,843 | CN¥226,823 | CN¥199,684 |
| Other Equity | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Equity | CN¥11,507,005 | CN¥11,164,181 | CN¥10,948,955 | CN¥10,665,096 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥3,594,067 | CN¥3,608,930 | CN¥4,089,257 | CN¥4,022,461 |
| Total Liab. & Tot. Equity | CN¥19,021,477 | CN¥18,833,373 | CN¥17,827,281 | CN¥16,198,325 |
| Net Debt | -CN¥3,486,619 | -CN¥3,614,264 | -CN¥5,167,255 | -CN¥8,885,034 |